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Abstract
Background: This study assesses the whole-genome gene expression changes in a panel of
primary human cell lines in response to DNA damage mediated by decay of DNA-incorporated
radioiodinated thymidine analog 5-[125I]iodo-2'-deoxyuridine (125I-IUdR). Three normal human cell
lines of different origin, namely, gingival fibroblasts AG09319, fetal skin fibroblasts GM05388 and
neonatal foreskin epidermal keratinocytes (NHFK) were used in this study. DNA molecules were
radiolabeled by incubation of cells in culture in a medium supplemented with either 3.7 kBq/ml or
18.5 kBq/ml of 125I-IUdR for 24 h followed by incubation in IUdR-free medium for additional 24
hours. Each experiment was carried out in quadruplicate. 125I-IUdR uptake was monitored by
measuring DNA-associated radioactivity. The whole-genome gene expression changes were
evaluated using Agilent Human Whole Genome oligo microarrays containing 44,290 elements
representing all known and predicted human genes. DNA microarray dataset was independently
partially validated with quantitative real-time PCR (RT-PCR).
Results: AG09319 gingival cells in culture responded to 125I-IUdR treatment by changing the
expression level of 335 genes in total, whereas under the same conditions GM05388 and NHFK
cells differentially expressed 49 genes and 27 genes, respectively. However, for GM05388 cells the
number of differentially expressed genes increases with the rise of 125I-IUdR concentrations in cell
culture media. The key up-regulated biological processes in a chosen panel of cell lines concern the
regulation of protein kinase activities and/or cell death. Genes repressed in response to 125I-IUdR
treatment are involved in cytokinesis, M phase of the cell cycle, chromosome architecture and
organization, DNA metabolism, DNA packaging, DNA repair and response to DNA damage.
Despite the disparate nature of the gene patterns elicited by 125I-induced DNA damage among the
different cell lines, the differentially expressed transcripts reveal strikingly non-random
chromosomal distribution in all the cell lines we used.
Conclusion: Our data suggest that DNA-targeted ionizing radiation produced by 125I-IUdR results
in changes in expression of only a limited subset of genes in primary human cells. The responsive
genes are distributed non-randomly among the chromosomes; and a significant fraction of them is
p53-dependent in the transcriptional regulation.
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Background
Exposure to ionizing radiation (IR) is inevitable occur-
rence for human beings. A variety of sources of IR, among
them environmental, accidental and medical being the
most important, contribute to a collective absorbed dose
of exposure to IR posing a challenge to human health and
well-being. The deleterious effects of IR are primarily due
to its known carcinogenic, mutagenic and cell-killing abil-
ity. One of the mechanisms underlying these effects is
thought to involve changes in gene expression following
IR exposure [1]. Recent technological advances and the
completion of Human Genome Project enabled scientists
to study global expression changes for tens of thousands
of genes at a time using powerful DNA microarray assays.
Many reports dealing with the identification of gene
expression profiles in human cells following IR exposures
were published so far, focusing on either high or low
dose-rate X-ray or gamma-ray exposures, responses in
tumor or normal cells; or, alternatively, comparing effects
of IR with other genotoxic agents [2-4]. However, very lit-
tle is known about whole-genome transcriptional
response of human cells to internally positioned radionu-
clides; the use of which for diagnostic and therapeutic
purposes constitutes the core of nuclear medicine practice.
In addition, such knowledge would be vital to implement
strategies aiming to minimize consequences of possible
nuclear power plant accidents or "dirty bomb" radiologic
terrorist attack in the future.
Auger electron emitters such as 125I have been proposed
for use in cancer therapy quite a long time ago [5]. DNA-
incorporated 125I-IUdR was shown to be very efficacious
(5- to 7-log cell killing) in the radiotherapy of small-ani-
mal malignancies [6]. Hence, there is steady interest in
developing the optimized protocols of 125I-IUdR adminis-
tration and other Auger electron emitters for possible clin-
ical trials in the future. However, a lack of comprehensive
information on how this radionuclide may affect the bio-
logical processes in treated cells at the molecular level
hampers progress in this application. In our previous
work, we showed that labeling of normal IMR-90 human
fibroblasts with 125I-IUdR triggers changes in gene expres-
sion of about ten times fewer genes as gamma-radiation
exposures delivered in bioequivalent doses [7]. We sug-
gested that the effect of IR on the changes in global gene
expression depends in part on the distribution of energy
depositions within the cell; and that DNA double-strand
breaks (DSBs) may not be the only factor modulating
changes in gene expression following irradiation.
Herein, we extend our studies of 125I-IUdR-induced
changes in gene expression on three primary human cell
lines. Our goal was to determine whether incorporation of
125I into DNA molecules of human cells is associated with
specific transcriptional changes that globally can be used
as a Auger effect "fingerprint," to identify functions of
genes whose expressions are altered following 125I decay;
to learn whether primary cells undergoing 125I-triggered
DNA damage show similar or disparate transcriptional
changes. By using oligo DNA microarrays to concurrently
compare the expression of about 41,000 transcripts in
radioactively labeled cells, we identified distinct transcrip-
tional perturbations that characterize the cellular response
to 125I-triggered DNA damage in human fibroblasts and
NHFK. Remarkably, we found that while genes showing
altered expression during 125I postlabeling differ dramati-
cally in these two types of cells, these genes were non-ran-
domly distributed among different chromosomes in both
types of cells.
Results
125I-IUdR-mediated DNA double-strand break induction
The rate of incorporation of 125I-IUdR into cellular DNA
was evaluated according to published protocols [8]. Decay
of 125I results in the emission of an average of 21 short-
range electrons most of them having energies below 1 keV
[9]. Therefore, nearly all energy of IR released upon decays
deposits within the few nanometers of the decay site [10].
With DNA-incorporated 125I, as in our study, this means
that DNA molecules are the targets of IR-mediated dam-
age whereas the energy deposition in the rest of the cell is
less than 5 % of that in the nucleus [9]. Assuming that one
decay of DNA-incorporated 125I produces one DSB, we
estimated that AG09319 cells in culture accumulated
about 59 DNA DSBs over the course of radiolabeling,
GM05388 cell cultures accumulated 32 DNA DSBs in
total, whereas NHFK cultures – about 30 DNA DSBs on
average, per our radiolabeling protocol [11]. Hence, DNA
molecules in targeted cell populations were irradiated at a
rate inflicting approximately 1–2 DNA DSBs per hour.
Gene expression changes mediated by DNA-incorporated 
125I-IUdR
DNA microarray analysis revealed that 335 transcripts
were responsive to 125I-mediated DNA damage in
AG09319 cells in culture, whereas 49 and 27 transcripts
were differentially expressed in 125I-IUdR-targeted
GM05388 and NHFK cells in culture, respectively (Figure
1). Out of 335 identified transcripts in AG09319 cell cul-
tures, 189 belong to named genes (see Additional file 1).
The majority of differentially expressed transcripts in
AG09319 cell cultures (171 transcript) were repressed in
response to 125I-mediated DNA damage, whereas 164
transcripts were induced (Figure 1A, B). Among up-regu-
lated genes we found genes involved in cell cycle regula-
tion (DUSP1,FGF2, SHC, and others) and regulation of
cell cycle checkpoints (CCNG1,CDKN1A, GADD45A, and
others). The major mechanism of regulation of cell cycle
for identified genes (CCNG1, CDKN1A, FGF2, GADD45A
and SHC1) is via modulation of protein kinase activityBMC Genomics 2007, 8:192 http://www.biomedcentral.com/1471-2164/8/192
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driving the cell cycle machinery. CDKN1A, GADD45A and
CCNG1 all contribute to cell cycle arrest following geno-
toxic stress; these genes are also among the best studied
and thoroughly validated markers of IR exposure [12,13].
In our study, we observed the up-regulation of several
genes (DUSP1, SHC1, PRDX5, TXNRD1, GLRX, and oth-
ers) thought to be involved in regulation of cell redox bal-
ance [14]. Surprisingly, many of 125I-induced genes in
AG09319 cells are implicated in formation and regulation
of cytoskeleton and extracellular matrix (TPM2, ACTA2,
TAGLN, FN1, CALD1, TIMP3, MMP2, KRTAP1-5, ARHE,
and others). This observation raises the issue of a possible
interconnection between DNA damage response and
likely downstream changes in cell shape and/or motility,
the finding that deserves to be addressed more specifically
in future. Among 171 down-regulated transcripts that
were responsive to 125I-mediated damage in AG09319
cells in culture, 88 transcripts belonged to named genes.
Of these, 25 genes are implicated in cell cycle regulation,
among them 17 genes being responsible for governing M
phase transition and/or cytokinesis (ANLN,  CCNA2,
CCNB1,  CDC2, CDC2L2,  CCNB2,  CDKN2C, CDKN3,
CKS1B, CKS2, KIF11, KIF23, KPNA2, PCNA, MAD2L1,
PRC1,  PTTG1,  RAD21,  SMC4L1, UBE2C and others).
Another large set of repressed genes is involved in DNA
metabolism, particularly in DNA replication, DNA repair
and/or DNA damage response (ADPRT, HMGB1,
HMGB2, PCNA, PTTG1, PTTG2, RAD21, RPA1, RRM1 and
RRM2). Several genes belonging to large gene families
were down-regulated in common in AG09319 cell cul-
tures; these include insulin-like growth factor binding
proteins (IGFBP3, IGFBP4 and IGFBP7), pregnancy-spe-
cific glycoproteins with unknown function (PSG1, PSG2,
PSG3, PSG6, PSG9 and PSG11), minor variants of his-
tones (H2AFX, H2AFV, H2AFZ, H3F3B and HIST1H4C)
implicated in DNA packaging and members of heteroge-
neous ribonucleoprotein family (HNRPA1, HNRPA2B1,
HNRPF, HNRPH1,  HNRPD, HNRPR and  HNRPU)
involved in RNA processing. Interestingly, the phosphor-
ylation of one of the histones identified, namely H2AFX,
is known to be one of the earliest events in DNA DSBs
response [15] and HNRPK was shown recently to be the
transcriptional co-activator of p53 in DNA damage
response [16]. However, whether the coordinated down-
regulation of identified gene families at the transcript level
serves the regulatory role in DNA damage response is not
clear.
We identified 16 125I-responsive differentially expressed
genes that were up-regulated in GM05388 and NHFK cell
cultures (Figure 1A; and see Additional files 2, 3). The
majority of induced genes in GM05388 cells are also
induced in AG09319 cells. These include CDKN1A,
GADD45A, DKK1, ARHE, FGF2 and FHL2. We found 33
125I-responsive differentially expressed genes that were
repressed in GM05388 cells and 11 genes down-regulated
in NHFK cell cultures (Figure 1B). HMGB1, HMGB2,
H2AFX, H2AFZ and HIST1H4C are among consistently
down-regulated genes in both AG09319 and GM05388
fibroblast cells. In contrast to fibroblast gene expression
profiles, the pattern of gene modulation in normal
human keratinocytes in response to 125I-induced damage
is distinct, with only two transcripts being common for
keratinocytes and any of fibroblasts tested.
We evaluated the magnitude of the changes in the expres-
sion level for 125I-responsive transcripts by comparing the
log fold-change values with the number of modulated
genes showing this change in expression (Figure 2; and see
Additional files 1, 2, 3). For the majority of differentially
expressed transcripts these alterations were less than 2-
fold comparing with control in all cell lines examined. For
AG09319 cell line, only 34 out of 335 transcripts identi-
fied showed more than 2-fold changes in their abun-
dance, and only a few of these transcripts (CDKN1A,
KRTAP1-5 and ARHE) were up-regulated. CDKN1A was
the only gene induced more than 2-fold in GM05388
cells, and no transcripts/genes appeared to be modulated
to such an extent in NHFK.
Effect of increasing concentration of 125I-IUdR in cell 
culture media on gene expression changes
In the previously described experiments, cells were radi-
olabeled by incubation in a medium supplemented with
3.7 kBq/ml of 125I-IUdR for 24 h followed by incubation
in IUdR-free medium for another 24 hours. However, in
separate experiments, the effect of 18.5 kBq/ml of 125I-
IUdR in a media was also evaluated. It was shown previ-
ously that there is a linear increase in DNA incorporation
of  125I-IUdR depending on concentration of this com-
pound in cell culture media [17]. We attempted to address
the question of whether the increasing concentration of
125I-IUdR in cell culture media qualitatively and/or quan-
Venn diagram of 125I-IUdR-responsive sets of either induced  (A) or repressed (B) genes Figure 1
Venn diagram of 125I-IUdR-responsive sets of either induced 
(A) or repressed (B) genes.
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titatively affect gene expression changes in primary
human cells. To this end, GM05388 cell line with a lack of
robust gene expression changes in response to 3.7 kBq/ml
of 125I-IUdR was exposed to 5-fold higher concentration
of 125I-IUdR (see Methods section for a detailed descrip-
tion). Surprisingly, the majority of differentially expressed
genes/transcripts modulated by different concentrations
of  125I-IUdR in cell culture media being induced or
repressed by either 3.7 kBq/ml or 18.5 kBq/ml concentra-
tions of 125I-IUdR are distinct (Figure 3). Only a few,
mainly p53-dependent, genes are modulated in common
by both concentrations. Such a non-linearity between the
dose of radiation and the effect of differential gene expres-
sion was observed recently for cultured human keratinoc-
ytes exposed to 0.2 Gy and 4 Gy doses of X-rays [18].
Interestingly, the increase in the number of differentially
expressed genes/transcripts modulated by DNA-incorpo-
rated 125I-IUdR in GM05388 cell line parallels the increase
of 125I-IUdR concentrations in cell culture media (Figure
3; and see Additional files 2 and 4).
Classification of differentially expressed genes in 
functional groups
Classification of genes in functional groups was done on
the basis of biological process categories from the Gene
Ontology Consortium (GO) [19]. Lists of all differentially
expressed genes identified by ANOVA test for each cell
line were compared to all annotated genes in the array by
using the categorical over-representation function of EASE
software [20]. We found that the key up-regulated biolog-
ical processes in a chosen panel of cell lines are the regu-
lation of protein kinase activity, regulation of cell cycle
machinery and/or cell death/apoptosis (Table 1). Genes
repressed in response to 125I-IUdR treatment are involved
in cytokinesis, M phase of the cell cycle, chromosome
architecture and organization, DNA metabolism, DNA
packaging, DNA repair and response to DNA damage
(Table 1). In our studies, 125I-IUdR-mediated gene expres-
sion profiles demonstrate the apparent induction of genes
involved in negative regulation of cell cycle via checkpoint
control and down-regulation of genes implicated in cell
transition through M phase and/or cytokinesis.
Non-random distribution of differentially expressed genes 
following 125I-IUdR labeling of the primary human cell lines
Analysis of 125I-IUdR-specific gene expression in human
cells shows that the incidence of genes either up-regulated
or down-regulated following radionuclide labeling varied
substantially on different chromosomes and was inde-
pendent of chromosome length (Figure 4). To investigate
a possible relationship between 125I-triggered gene expres-
sion and gene location, chromosomal positions for
probes represented on Agilent Whole Human Genome
arrays were retrieved. As shown in Figure 4, a dispropor-
tionately high number of up-regulated 125I-specific genes
were located on chromosomes 19, 7, 5, and 11 (for
AG09319 cell line), on chromosomes 5, 10, 16, 7 and 15
(for GM05388 cell line) and on chromosomes 22, 18 and
12 (for NHFK). Similarly, we observed a non-random
enrichment of 125I-repressed genes on chromosomes 4,
13, 10, 15 and 1 (for AG09319 cells), on chromosomes 6,
15 and 5 (for GM05388) and on chromosomes 6, 15, 8
and 4 (for NHFK). This disproportionality was independ-
ent of the density of ascertained genes on these chromo-
somes. For example, chromosomes 19 and 3 contained a
similar number of genes (1,928 and 1,933, respectively),
but 4.5 times as many number of genes on chromosome
19 showed up-regulation after 125I-IUdR-induced DNA
damage in AG09319 cell line.
Real-time PCR validation of DNA microarray data
Six selected genes were further analyzed by real-time,
quantitative PCR to validate the results obtained using
125I-IUdR-responsive sets of either induced (A) or repressed  (B) genes in GM05388 human cells Figure 3
125I-IUdR-responsive sets of either induced (A) or 
repressed (B) genes in GM05388 human cells. Differ-
ent concentration of 125IUdR in cell culture media was used.
18.5 kBq/ml – 69 genes 3.7 kBq/ml – 16 genes
9 60 7
CDKN1A
GADD45A
DKK1
FHL2
ARHE
A
3 68 30
B
18.5 kBq/ml – 71 genes 3.7 kBq/ml – 33 genes
HMGB2
Log fold-change distribution in the expression level of 125I- IUdR-responsive genes in primary human cell lines Figure 2
Log fold-change distribution in the expression level of 
125I-IUdR-responsive genes in primary human cell 
lines. Shown in white – AG09319 cells, in grey – GM05388 
cells, in black – NHFK.
0
5
10
15
20
25
30
35
40
>-1.8 -1.6 >-1.4 -1.2 >-1 -0.8 >-0.6 <0.6 0.8 <1 1.2 <1.4 1.6 <1.8 2
Fold-repressed Fold-induced
N
o
.
o
f
g
e
n
e
sBMC Genomics 2007, 8:192 http://www.biomedcentral.com/1471-2164/8/192
Page 5 of 12
(page number not for citation purposes)
DNA microarray (Table 2). These genes (CDKN1A,
GADD45A, IGFBP3, H2AFX, TRIM22 and FHL2) showed
different magnitude of either induction or repression fol-
lowing 125I-IUdR treatments in different cell lines as deter-
mined by our DNA microarray studies. Also, these genes
were picked up for additional in-depth study because they
are involved in different cellular functions. For each gene,
RT-PCR reactions were performed using three replicate
independent RNA samples of different cell lines. RT-PCR
was done three times for each sample, and the data were
averaged and normalized to 18S RNA amount. The rela-
tive ratios of transcript amounts in 125I-IUdR-treated and
127I-IUdR-treated samples were compared with microar-
ray data of the matched input RNA sample by taking into
account the mean values and standard errors of measure-
ment representing at least three independent replicate
experiments for DNA microarray and RT-PCR studies
(Table 2). The results confirmed the similar transcrip-
tional response for all six genes tested with two independ-
ent techniques, namely, DNA microarray and RT-PCR
assays, thus proving the accuracy and reproducibility of
our DNA microarray dataset.
Discussion
The primary goal of our study was to characterize the
response of primary human cells to irradiation from
DNA-incorporated radionuclide in a form of the thymi-
dine analog 5- [125I]iodo-2'-deoxyuridine (125I-IUdR) in
terms of gene expression changes. To date, there was only
one report addressing the effect of a cell-incorporated
radionuclide (35S) on gene expression changes in human
colorectal carcinoma cells [21]. That study showed that
35S-methionine induces a much more robust transcrip-
tional response than gamma-radiation exposure. But this
limited information was available only for a few thousand
of human genes. Our study is the first to use a whole-
genome DNA microarray platform covering all known
and predicted genes to assess the effect of cell-incorpo-
rated radionuclide (125I) on transcriptional response in
primary human cells. It is well-known that decay of DNA-
incorporated  125I induces mainly DNA double-strand
breaks (DSBs) while producing little damage to the rest of
the cell [17,22]. That the transcriptional responses to ion-
izing radiation administered as external beam irradiation
vary widely in cell lines with different tissues of origin and
different genetic backgrounds was shown in previous
studies [12]. Our study is the first to demonstrate the het-
erogeneity of normal human cell responses to internal
irradiation, highlighting the importance of cellular con-
text for reaction to DNA DSB formation. Only a few 125I-
IUdR-responsive genes, mainly showing p53-dependent
regulation, are modulated in common in the several
human cell lines we tested. In our previous study we
found that expression of 206 genes was altered in normal
human lung IMR-90 fibroblasts, with a distinct transcrip-
tional profile sharing only a few genes in common with
Table 1: Functional annotation of selected overrepresented Gene Ontology categories as determined by EASE
Up-regulation Down-regulation
Cell Line Biological processes EASE score Biological processes EASE score
AG09319 Cytokinesis 1.09E-15
Regulation of enzyme activity 0.0001 Cell cycle 9.68E-13
Regulation of protein kinase activity 0.0013 M phase 1.95E-12
Regulation of cell size 0.0038 DNA metabolism 1.62E-07
Negative regulation of signal RNA processing 3.32E-06
transduction 0.0116 Chromosome organization 0.0001
Regulation of cell proliferation 0.0158 Cytoskeleton organization 0.0002
Positive regulation of apoptosis 0.0186 DNA replication 0.0002
Activation of MAPK 0.0236 DNA repair 0.0013
Cell redox homeostasis 0.0485 Response to DNA damage 0.0021
DNA packaging 0.0022
Primary metabolism 0.0083
GM05388 (3.7 kBq//ml) Regulation of protein kinase activity 0.0014 DNA base excision repair 0.0022
Regulation of enzyme activity 0.0048 DNA metabolism 0.0134
Cell cycle arrest 0.0335 DNA packaging 0.0174
Cell cycle 0.0453 Chromosome organization 0.022
Cytoskeleton organization 0.0376
GM05388(18.5 kBq/ml) Cell death 0.0028 M phase 7.63E-06
G1/S transition of mitotic cell cycle 0.0067 Chromosome organization 0.0004
Cell cycle 0.0008
Cytokinesis 0.0058
DNA packaging 0.0139
Protein metabolism 0.0430BMC Genomics 2007, 8:192 http://www.biomedcentral.com/1471-2164/8/192
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AG09319 and GM05388 cells used in the present study
[7]. This, in fact, is consistent with the published data
showing a surprisingly little overlap for genes differen-
tially expressed in various cell lines following external
beam IR exposure in the same dose [12,23]. For example,
it was shown recently that only 13 genes out of 463 genes
up-regulated by more than 2-fold following IR exposure
in 2 Gy were shared by three different cell lines used [23].
The observed lack of consensus gene expression changes
in normal human cells in response to internal irradiation
can be explained by the recent finding showing that trans-
lational level of gene expression regulation following gen-
otoxic stress might be crucial [24]. In addition, since the
cell lines used in our study represented distinct differenti-
ated cell types and/or tissues of origin, specific transcrip-
tional programmes are likely to be operative in these cells
favoring expression of unique sets of genes which might
be distinct for each cell line. This assumption is reinforced
by the observation that two fibroblast cell lines that we
used in the present study shared 35 differentially
expressed genes compared to only 3 genes that were com-
mon to keratinocytes as well (Figure 1); thus, fibroblasts
of different tissues of origin are being more closely related
to each other than to keratinocytes with regard to 125I-
IUdR-driven changes in gene expression.
In contrast to the majority of microarray-based papers
published so far addressing the gene expression changes
in human cells in response to external gamma-radiation
exposure, we found that the limited subset of genes is dif-
ferentially expressed in normal 125I-IUdR-labeled, pri-
mary human cells. This finding implies that DNA DSB
induced by 125I decay in human cells that is believed to be
hard to repair is not able to elicit robust transcriptional
Non-random chromosomal distribution of differentially expressed genes after 125I-IUdR treatment of human cells Figure 4
Non-random chromosomal distribution of differentially expressed genes after 125I-IUdR treatment of human 
cells. Shown on X axis is the chromosome number, shown on Y axis is the normalized fraction of differentially expressed 
genes on a given chromosome. Patterned bars in front represent upregulated genes, open bars represent down-regulated 
genes. A – AG09319 cells, B – GM05388 cells (18.5 kBq/ml of 125IUdR), C – GM05388 cells (3.7 kBq/ml of 125I-IUdR), D – 
NHFK cells.
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response regardless the well-known deleterious effect of
DNA-incorporated 125I on cell survival. Interestingly, that
there is no apparent relationship between the genes nec-
essary for survival from the DNA-damaging agents and
those genes whose transcription is increased after genoto-
xic stress exposure is already shown for yeast [25]; in light
of our findings, this may be true for human cells as well.
This assumption is reinforced by our observation that by
the time when 125I-IUdR-induced gene expression altera-
tions were examined in primary human cells, no signifi-
cant changes in cell viability occurred as judged by trypan
blue cell exclusion assay with more than 90% of cells
being viable.
We found that a significant fraction of induced genes in
fibroblast cell lines are p53-dependent in their transcrip-
tional regulation. This set of genes include established
p53-targets like CDKN1A,  GADD45A,  CCNG,  PLAB,
DUSP1, FHL2, SERPINE1, IGFBP3, DKK1 and also pre-
dicted targets of TP53 like IGFBP4, ANXA4, FGF2, ACTA2,
FN1, CALD1 and TIMP3 [26]. As was the case for induced
genes, many of repressed genes found are known to be
regulated by p53, for example PCNA,  PTTG1,  CCNB1,
PRC1,  RRM2,  CCNB2,  CDKN2C,  PTMA,  KPNA2,
MAD2L1, CBX1 and HMGB2 [26]. However, the fraction
of these verified and predicted targets of p53 in repressed
set of genes is considerably smaller than that for up-regu-
lated genes.
External IR exposure can induce the transcription of spe-
cific genes through the activation of not only p53 but also
NF-κB and AP-1 [27]. External gamma-irradiation results
in damage to the subcellular constituents distributed
more or less uniformly across the entire target cell volume.
Using external gamma-radiation as a genotoxic stress
agent, expression level modulation of thousands of genes
in normal human cells was reported recently [3]. In con-
trast, our study shows that DNA-targeted IR-induced dam-
age elicited by 125I-IUdR results in an order of magnitude
less robust transcriptional response. That only the limited
subset of genes, many of which are known components of
p53-signaling network, is implicated in response to 125I-
IUdR-triggered DNA damage may be the consequence of
the limited repertoire of the sensing pathways involved in
detection of such damage. Indeed, the key proteins of
DNA DSBs signaling such as ATM and components of
MRN complex are localized in the nucleus that is the tar-
get for 125I-mediated damage. ATM is known to be acti-
vated by just a few DNA DSBs following IR exposure [28],
that, in turn, triggers the plethora of downstream ATM-
dependent responses including the accumulation of p53
and increased binding affinity of p53 to transcriptional
targets [29]. Thus, the activation and/or repression of
downstream p53 target genes are the consequences of 125I-
mediated DNA damage.
In contrast, NF-κB and AP-1 normally reside in the cyto-
plasm in the inactive state requiring oxidative conditions
in the cytoplasm for their activation [30]. The decays of
DNA-incorporated 125I produce little damage to the cyto-
plasm of treated cells that is likely to be insufficient for the
activation of these transcription factors thus explaining
the prominent role of p53 signaling network following
DNA-targeted damage. In support of this view, the
increase of 125I-IUdR incorporation into DNA in
GM05388 cells in our studies parallels the increase in the
number of differentially expressed genes. Provided that
following decay of DNA-incorporated 125I the energy dep-
osition in cytoplasm is less than 5 % of that in the
nucleus, it is likely that the increased number of decays of
DNA-incorporated  125I results in oxidative stress condi-
tion in cytoplasm giving rise to activation of some addi-
tional signaling pathways as well. Interestingly, the
cellular responses to "high" (18.5 kBq/ml) and "low" (3.7
kBq/ml) concentrations of 125I-IUdR in cell culture media
were so apparently distinct, that they resemble the recent
finding of putative exclusive "low-dose" and "high-dose"
gene responders following either IR exposure of cultured
normal human cells or irradiation of the whole mice in
different doses [18,31,32]. Indeed, in an effort to develop
gene expression signatures that predict IR exposure in
mice and humans, only 5 genes out of total 225 genes
found to be modulated in peripheral blood cells in mice
exposed to increasing doses of either 0.5 Gy, 2 Gy or 10 Gy
of IR were common to all these exposures [32]. What
emerges from these studies is that there is no "clear-cut"
Table 2: Comparison of DNA microarray and real-time PCR 
measurements. Shown are the mean and the standard error of 
the mean for at least three independent experiments.
Microarray ratio RT-PCR ratio
Gene symbol Cell line Mean ± SEM Mean ± SEM
CDKN1A AG09319 4.17 ± 0.75 2.72 ± 0.22
GM05388 3.45 ± 0.48 2.99 ± 0.49
NHFK 1.17 ± 0.20 1.17 ± 0.22
GADD45A AG09319 1.77 ± 0.24 1.37 ± 0.31
GM05388 1.57 ± 0.35 1.23 ± 0.17
NHFK 0.90 ± 0.15 0.79 ± 0.18
IGFBP3 AG09319 1.59 ± 0.11 1.06 ± 0.13
GM05388 1.15 ± 0.22 1.10 ± 0.17
NHFK 1.16 ± 0.06 0.74 ± 0.41
H2AFX AG09319 0.41 ± 0.05 0.18 ± 0.06
GM05388 0.62 ± 0.13 0.41 ± 0.15
NHFK 0.80 ± 0.21 0.70 ± 0.21
FHL2 AG09319 1.79 ± 0.31 0.97 ± 0.11
GM05388 1.75 ± 0.46 1.15 ± 0.17
NHFK 1.16 ± 0.40 1.03 ± 0.27
TRIM22 AG09319 1.38 ± 0.17 1.07 ± 0.17
GM05388 1.95 ± 0.41 1.63 ± 0.13
NHFK 1.82 ± 0.54 2.22 ± 1.20BMC Genomics 2007, 8:192 http://www.biomedcentral.com/1471-2164/8/192
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dose-response effect for the vast majority of IR-induced
genes and that distinct biological processes are modulated
as a function of IR dose. In our present study, we found
that only a few, mainly p53-dependent, genes like
CDKN1A, GADD45A, DKK1, FHL2 are modulated in com-
mon by two various concentrations of 125I-IUdR. Interest-
ingly, the most robust transcriptional response among the
cell lines we used was seen for AG09319 fibroblasts
which, by our estimation, accumulated almost two times
more DNA DSBs compared to either GM05388 or NHFK
cells (see Methods section). The increase in the number of
modulated genes also seems to be dependent on the
amount of 125I-IUdR as the higher (18.5 kBq/ml) concen-
tration of 125I-IUdR in cell culture media apparently
results in the larger number of genes being modulated by
internal IR. This might, at least, in part explain why the
number of genes responding to 125I-IUdR treatment was
very different within the three cell lines. However,
whether the threshold for modulation of gene expression
exists in case of 125I-IUdR-triggered DNA damage is pres-
ently not clear.
By calculating the ratios of relative gene expression
changes following either 125I-IUdR or 127I-IUdR cell cul-
ture treatment, we have determined the magnitude of
transcriptional response to 125I-elicited DNA damage in
normal human cells. As indicated in our results (Figure 2),
only a few genes/transcripts changed their expression level
more than twofold. Such small changes at a global level
after IR exposures were reported previously by several
groups, both in human cell fibroblast and mouse studies
[18,33]. The minimal fold change in the set of genes iden-
tified by ANOVA as being differentially expressed in our
study was 1.35 – 1.4, which is close to a cutoff value used
in a recent paper [31]. The biological significance of such
a change depends on the particular gene under considera-
tion. However, we have achieved a good cohort of DNA
microarray and real-time PCR datasets that closely parallel
each other even when the changes in gene expression are
small. This agreement between two independent tech-
niques used for gene expression studies implies that the
small changes underlying the cellular response to 125I-trig-
gered DNA damage we observed in our experiments are
significant and reliable.
Our results suggest that the cell cycle-related processes
dominate over all other 125I-perturbed pathways at the
transcriptome level. These findings may be explained by
the fact that almost all 125I-IUdR is incorporated in cellu-
lar DNA during S-phase. DNA DSBs formation through-
out the G2 phase is likely to activate one of the key
components of the DNA damage response, namely p53
[34]. p53 can act as an effector in inducing the G2/M
block through the induction of CDKN1A,  GADD45A,
CCNG1 and the repression of CCNB1 and CCNB2. Also,
p53 was recently mechanistically linked to the cytokinesis
providing the negative feedback for this process [35].
Although the gene expression profile characteristic for
125I-triggered DNA damage clearly suggest the ongoing
cell cycle arrest in targeted cell cultures, it is unknown
whether this halt in cell proliferation is reversible or not.
Interestingly, a subset of the 125I-responsive genes is repre-
sented by known cellular senescence markers. These
include up-regulated SERPINE1,  SERPINE2,  CDKN1A,
SHC1, IGFBP3, IGFBP7, SPUVE, CITED2, S100A4, FN1,
PSG1, CALD1, TAGLN, GLRX, LOXL2, ATP6V0C, SPARC,
DKK1,  DKK3,  CAP2,  CTGF  as well as down-regulated
PPP1CC,  H3F3B,  CDC2,  RBBP7,  HNRPH1,  PTMA  and
CCNA2  in AG09319 cells; induced CDKN1A,  PERP,
RPS27L,  FST  and  DKK1  as well as repressed CCNA2,
EIF3S6 and HNRPF in GM05388 cells; and TM7SF3 in
NHFK cells. This suggests that the cellular senescence is
likely be triggered in response to DNA damage elicited by
125I in at least fibroblast cell lines we tested [36].
Chromosomal clustering of genes whose expression was
up-regulated during replicative senescence was recently
observed in primary human fibroblast and epithelial cells
[36]. Since we identified many senescence-related genes as
being differentially expressed following 125I-triggered
DNA damage in our studies, we wished to examine the
chromosomal distribution of induced and repressed
genes more closely. That the differentially expressed 125I-
responsive genes reveal non-random distribution across
distinct chromosomes was a surprising finding that was
never reported in the literature for radiation-induced gene
profiles before. 125I-IUdR is incorporated into cellular
DNA at S phase of the cell cycle presumably in a random
order; the non-random chromosomal distribution of dif-
ferentially expressed genes cannot be explained by the fact
that 125I-IUdR had incorporated predominantly to some
specific chromosomes since we grew our asynchronous
cell cultures in a medium supplemented with 125I-IUdR
for 24 hrs that is approximately the population doubling
time for all cell lines we used. A follow-up analysis of our
earlier results on DNA microarray studies of gene expres-
sion changes in normal human fibroblasts after both
high-dose rate and low-dose rate external beam gamma-
radiation exposures [7] revealed random distribution of
induced genes across different chromosomes, even if only
a random subset of genes comparable in size to that
observed following 125I-IUdR exposure, was examined
(data not shown). Interestingly, the non-randomness
observed in our present study was found to be a character-
istic of not only the induced but also the down-regulated
genes which is in contrast to earlier evidence on replica-
tive senescence [36]. This apparent discrepancy is likely to
be explained by the different triggers of senescence in
these cases – e.g. shortening of telomeres resulting in the
replicative senescence or 125I-induced DNA damage possi-BMC Genomics 2007, 8:192 http://www.biomedcentral.com/1471-2164/8/192
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bly leading to premature stress-induced senescence. Previ-
ous data that histone deacetylase inhibitors, that
decondense chromatin, induce a senescence-like state in
human fibroblasts suggested that the opening of certain
chromatin domains (for example, conversion of hetero-
chromatin to euchromatin) may be a feature of replicative
senescence [37]. Following 125I-IUdR treatment of cells we
found extensive down-regulation of many genes whose
products are involved in chromatin condensation (such as
HCAP-G and eight distinct members of histone H1 family
in GM05388 cells). It is possible that highly localized
DNA damage elicited by 125I decay also leads to the relax-
ation of higher-order chromatin structures in the vicinity
of the site of decay and to the opening of some chromatin
domains thus recapitulating some features of histone
deacetylase inhibitor-induced premature senescence.
It is known that DNA DSBs are intentionally formed in
human cells under some strictly controlled conditions, for
example in meiosis and in VDJ recombination. Recent evi-
dence suggest that a topoisomerase IIβ-mediated DNA
DSB is normally required for regulated transcription [38]
as well. Upon binding of nuclear receptors to the target
gene, Topoisomerase IIβ creates a nucleosome-specific
DNA double-strand break that triggers PARP-1's intrinsic
catalytic activity, resulting in poly(ADP-ribosyl)ation of
chromatin-associated proteins. This leads to the exchange
of histone H1 for high mobility group B (HMGB) proteins
during this gene-specific transcriptional activation [38]. It
was shown that topoisomerase IIβ-mediated DNA DSB is
required for efficient transcription initiation for at least
five different promoters; therefore, it is highly likely that
this phenomena is general. The emerging view that the
transcription is far more widespread in human cells than
it was thought before suggests that all of the non-repeat
portions of the human genome are transcribed [39]. Even
though 125I-IUdR is incorporated into cellular DNA at ran-
dom sites, given the estimates that 90% of the human
genome are transcribed [40] makes it reasonable to
assume that some 125I decays may occur within promoter
regions. Interestingly, we observed strong down-regula-
tion of HMGB genes (HMGB1 and HMGB2) upon 125I-
IUdR labeling in all fibroblast cell lines we used. PARP-1
was also repressed in GM05388 cells. These findings raise
the possibility that fibroblasts can somehow distinguish
Topoisomerase IIβ-induced "physiological" DNA DSBs
from 125I-IUdR-induced DNA DSBs; the resulting altera-
tion in cellular signaling may lead to regulated repression
of the components of machinery that normally helps
DNA transcription to start, at least for some gene targets.
The comparison of gene expression profiles following
exposure of human cells to the same compound, labeled
either with "hot" or "cold" iodine, allowed us to rule out
all possible side effects of addition of 125I-IUdR into the
cell culture media other than direct genotoxicity. Such
"clear-cut" discrimination of genotoxic mode of action of
the drug in gene expression studies was done, to the best
of our knowledge, for the first time. The results of our
present study imply that DNA-targeted 125I-triggered dam-
age appears to modulate the gene expression changes of a
limited subset of genes in primary human cells. This may
prompt to reconsider the findings of the previously pub-
lished experiments on genomic profiling of human cells
following IR exposures in that the "DNA damage respon-
sive" subsets of genes identified perhaps should be
regarded as "IR responsive" [3,41,42]. In practical terms,
the biological deleterious effects stemming from DNA-tar-
geted IR-induced damage such as that induced by DNA-
incorporated 125I is easily explained at the molecular level,
given the persistence of DNA damage in cell cultures fol-
lowing continuous accumulation of 125I decays, the
repression of several major components of DNA repair
machinery and the lack of robust response to DNA-tar-
geted IR damage at least at the transcriptome level
observed in our study.
Conclusion
Our data suggest that DNA-targeted ionizing radiation
produced by 125I-IUdR results in changes in expression of
only a limited subset of genes in primary human cells. The
responsive genes are distributed non-randomly among
the chromosomes; and a significant fraction of them is
p53-dependent in the transcriptional regulation.
Methods
Tissue culture
Human primary cell lines of different origin, namely, gin-
gival fibroblasts AG09319 (population doubling level,
PDL 22) and fetal skin fibroblasts GM05388 (PDL 21;
both from Coriell Cell Repositories) were grown in Eagle's
minimum essential medium (EMEM; ATCC) supple-
mented with 10% FBS, non-essential amino acids, 1 mM
sodium pyruvate and 2 mM L-glutamine in a humidified
5% CO2 incubator at 37°C. Neonatal foreskin epidermal
keratinocytes (NHFK, PDL 19) pooled from several
donors' explants (Coriell Cell Repositories) were culti-
vated in Keratinocyte-SFM (Invitrogen) supplemented
with L-glutamine, epidermal growth factor (0.2 ng/ml)
and bovine pituitary extract (30 µg/ml) under the same
conditions. Since it is known that primary normal human
cells have a finite lifespan in culture, the choice of cell
lines used in this study was dictated by the availability of
primary human cells with the lowest passage number
attained in culture provided by the Coriell Cell Repositor-
ies.
125I-IUdR radiolabeling
Iodine-125 labeled iododeoxyuridine (specific activity
~74 TBq/mmol) was purchased from MP Biomedicals.BMC Genomics 2007, 8:192 http://www.biomedcentral.com/1471-2164/8/192
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The desired radioactive concentration was obtained by
dilution of the 125I-IUdR in fully supplemented EMEM.
On a day before radiolabeling, the cells were subcultured
so that they reached approximately 50% confluence on
the next day. The cell cultures were divided into two
batches. One batch was radiolabeled by cell incubation in
a medium supplemented either with 3.7 kBq/ml of 125I-
IUdR or with 18.5 kBq/ml of 125I-IUdR (GM05388 cells)
for 24 h followed by incubation in IUdR-free medium for
another 24 hours. The second batch of cell cultures, served
as a control, was incubated under identical conditions
except that 125I-IUdR was substituted for the equimolar
concentration of non-radioactive 127I-IUdR (Sigma). Each
experiment was carried out independently four times.
Given that asynchronous cell populations were used for
125I-IUdR treatment, we chose to perform cell radiolabe-
ling over 24 hours which approximately corresponds to
duration of one cell cycle; therefore, all cycling cells were
destined to incorporate 125I-IUdR and be exposed to inter-
nal IR. None of these treatments had a marked effect on
viability of cell cultures by the end of the exposure as
measured by the trypan blue exclusion assay; nuclei integ-
rity was maintained in 125I-IUdR-treated cells providing
no evidence for apoptosis as observed by DAPI nuclei
staining (data not shown).
125I-IUdR uptake studies
A separate experiment was run in parallel with that
described above. Following incubation in either 125I-IUdR
or  127I-IUdR-containing media according to described
protocol (see 125I-IUdR Radiolabeling), the labeled cells
were trypsinized and counted; the cell pellets were washed
in phosphate buffered saline (PBS; Invitrogen) and the
DNA-incorporated activity in known numbers of cells was
determined following trichloroacetic acid (TCA; Sigma)
precipitation [8] using a γ -counter (Biotraces).
RNA sample preparation, probe labeling and DNA 
microarray procedure
Total RNA was extracted using Trizol (Invitrogen), and
then purified sequentially with RNeasy kit (Qiagen) and
TURBO DNA-free kit (Ambion) per instructions of the
suppliers. The amount and quality of RNA preparations
were evaluated on the Agilent 2100 Bioanalyzer with RNA
6000 Nano Reagents and Supplies (Agilent). Subse-
quently, cDNA targets were synthesized from 20 µg of
total RNA in each reaction and fluorescently labeled with
either Cy3-dCTP or Cy5-dCTP using the Agilent Fluores-
cent Direct Label kit. Then, the cDNA targets correspond-
ing both to 125I-IUdR- or 127I-IUdR-labeled samples per
each cell line were combined and hybridized to 44,290-
element Agilent Human Whole Genome oligo microar-
rays using Agilent SureHyb hybridization chambers;
methods for microarray hybridization and washing were
as described in manufacturer's protocol. Hybridized DNA
microarrays were scanned with a resolution of 5 µm on a
VersArray ChipReader scanner (Bio-Rad, Inc.), and TIFF
images were processed by VersArray Analyzer 4.5 software
(Media Cybernetics, Inc.). All samples had four independ-
ent biological replicates, and each replicate was run on
separate slides.
Data analysis
Raw intensity profiles were analyzed using BRB-Array-
Tools Version 3.2.2 software developed by Dr. Richard
Simon and Amy Peng Lam (Biometric Research Branch,
National Cancer Institute, NIH). The input for this analy-
sis included 127I-IUdR-treatment versus 125I-IUdR-treat-
ment data to determine the 125I-responsive genes from
four independent experiments per each cell line. Differen-
tially expressed genes were identified using a random var-
iance ANOVA test. Changes in gene expression were
considered statistically significant if the p values for corre-
sponding genes were less than 0.005. The false discovery
rate (FDR) was controlled to be less than 10%. The result-
ant sets of differentially expressed genes were further ana-
lyzed for functional significance using the program EASE
(version 2.0). This software obtains the Gene Ontology
(GO) annotations from a database and generates a statis-
tical analysis of the functional annotations that are over-
represented in the inputted list of genes [20], with a
Bonferroni correction for multiple comparisons included.
GO biological processes with EASE scores less than 0.05
were considered to be statistically significant [43]. The
analysis of the distribution of differentially expressed
genes on different chromosomes was done with the help
of BRB-ArrayTools Version 3.2.2 software, including the
assignment of all spotted and differentially expressed
genes to specific chromosomes. The normalized fraction
of differentially expressed genes is calculated based on the
relative enrichment of these modulated genes on a given
chromosome.
Minimum Information About a Microarray Experiment
(MIAME)-compliant raw data for this series of experi-
ments have been deposited in the ArrayExpress database
maintained by the European Bioinformatics Institute
(accession no. E-MEXP-929) [44].
Quantitative real-time PCR
In total, six genes were chosen for RT-PCR validation. The
RT-PCR was performed on three replicate independent
RNA samples for each cell line. The complementary DNA
was synthesized from total RNA by reaction with Multi-
Scribe reverse transcriptase and random primers (both
from High Capacity cDNA Archive kit; Applied Biosys-
tems) according to the manufacturer's protocol. For each
gene, PCR reactions were run three times on one sample.
PCR was performed on iCycler iQ (Bio-Rad, Inc.) in 20-µl
reactions by using TaqMan Assay-on-Demand primers/BMC Genomics 2007, 8:192 http://www.biomedcentral.com/1471-2164/8/192
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probe sets (Applied Biosystems). IDs of the TaqMan
Assay-on-Demand primers/probe sets used are as follows:
Hs00355782_m1 ( CDKN1A), Hs00169255_m1
(GADD45A), Hs00181211_m1 ( IGFBP3),
Hs00266783_s1 (H2AFX), Hs00179935_m1 (FHL2) and
Hs00232319_m1 (TRIM22). The reaction was repeated
for 40 cycles; each cycle consisted of denaturing at 95°C
for 15 s, annealing and synthesis at 60°C for 1 min as per
manufacturer's instructions. Real-time PCR data were ana-
lyzed using the comparative CT method within the log-
linear phase of the amplification curve obtained for each
primers/probe set [13]. The relative amounts of transcript
of the tested genes were normalized by 18S rRNA endog-
enous control primers/probe set. The average ratios of rel-
ative amounts of transcript in 125I-IUdR-treated versus
127I-IUdR-treated cells from three replicate runs were cal-
culated.
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